EnWave Corporation

EnWave Corporation

June 02, 2009 16:00 ET

EnWave Grants Director & Officer Options

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 2, 2009) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that, upon recommendation of its Compensation Committee, it has granted 350,000 stock options to certain Directors and Officers of the Company. Stock options were also granted to certain employees and consultants. Each option will entitle its holder to purchase one common share of the Company at an exercise price of $0.35 per share for a period of five years from this date. The grant is made pursuant to the Company's Share Option Plan ("the Plan"), approved by a majority of disinterested shareholders of the Company on March 11, 2008. The options will vest in accordance to provisions set out in the Plan, or as otherwise required by the TSX Venture Exchange. Any shares issued on exercise of these options will be restricted from trading for a period of four months from this date as required by TSX Venture Exchange policies and securities legislation. The grant is subject to regulatory approval.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREV™, powderREV, bioREV™ and freezeREV brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Mr. John McNicol, President & Co-CEO

This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's REV technology can or will improve dehydration processes in the target industries; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

The TSX Venture Exchange has neither approved nor disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information